# DEFERASIROX

NDC: 59651-412
Generic name: DEFERASIROX
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20231016

FDA application: ANDA214474

## Active ingredients

- DEFERASIROX: 360 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-412"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-412
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7f14819-1abc-4abf-b55b-cf89beaf124e